PFSA
Profusa, Inc.
$0.09
-0.04 (-27.69%)
At close · Jul 2
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred significant net operating losses from operations. As of March 31, 2026, the Company had a working capital deficit of approximately $28.4 million. For the three months ended March 31, 2026, the Company incurred a net loss of $3.5 million and used $2.6 million of cash in operating activities. Management expects to continue to incur additional substantial losses in the foreseeable future as a result of research and development activities.”View the 10-Q filed May 15, 2026
Market Cap
$435,735
Shares
4,660,268
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.09
Open$0.13
Day$0.08–0.13
52W$0.08–412.50
Avg vol 30d5.3M
Short int123K · 2.6% float · 1.0d
Short vol49%
DataJul 2025–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−99% below
−
Price vs 50-day avg
−74% below
◦
RSI (14)
26 · oversold
+
MACD trend
positive
−
52-week position
0% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $0 › 200d $8 — 200d above 50d
+
Institutional flow
+9 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
2.65% of float · ▼ -57.2% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
9 holders — 13F breadth
Fundamentals
Strong
+
EPS growth
+70% Y/Y
−
Free cash flow
$-16.3M
+
Balance sheet
net cash $1.8M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−99% below
Bearish
Price vs 50-day avg
−74% below
Bearish
RSI (14)
26 · oversold
Neutral
MACD trend
positive
Bullish
52-week position
0% · near low
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $8 — 200d above 50d
Institutional flow
Accumulating
+9 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.65% of float · ▼ -57.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
9 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $0
Now $0 · 0%
52-wk high $413
vs 200-day avg -99%
vs 50-day avg -74%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PFSA
this stock
Profusa, Inc.
|
$435,735 | -98.8% | — | — | 2.6% |
|
ABT
Abbott Laboratories
|
$166.17B | -23.5% | +5.7% | 26.7 | 1.3% |
|
SYK
Stryker Corp
|
$125.18B | -6.8% | +11.2% | 37.8 | 1.6% |
|
MDT
Medtronic plc
|
$106.49B | -12.7% | +8.4% | 22.3 | 1.4% |
|
BSX
Boston Scientific Corp
|
$67.09B | -52.7% | +5.5% | 18.9 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PFSA | -20.3% | -70.4% | -98.7% | -19.7% | -98.8% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -21.8% | -69.1% | -106.7% | -19.4% | -108.0% |